Trial site
EMC Instytut Medyczny S.A.
- 36running trials
- 15closed trials
The trials here
What the 52 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis19 trials
- Crohn's disease11 trials
- Atopic dermatitis (eczema)4 trials
- Hidradenitis suppurativa3 trials
- Multiple sclerosis3 trials
- Prostate cancer3 trials
- Chronic spontaneous urticaria2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Vitiligo2 trials
- Alopecia areata1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Liver cirrhosis1 trial
- and 3 more
- Phase
- Phase 329 trials
- Phase 219 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting18 trials
- Recruiting17 trials
- Completed15 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Pfizer5 trials
- Incyte Corporation4 trials
- Hoffmann-La Roche3 trials
- Amgen Inc.2 trials
- and 27 more
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Recruiting
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Recruiting
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Active, not recruiting
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Recruiting
Recruiting
Active, not recruiting
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Active, not recruiting
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Recruiting
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease6 recruiting
- Ulcerative colitis5 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Chronic spontaneous urticaria1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Hidradenitis suppurativa1 recruiting
- Liver cirrhosis1 recruiting
- Multiple sclerosis1 recruiting
- Vitiligo1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Completed
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Completed
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
Completed
Completed
Completed
Completed
VTX002 versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis
Completed
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026